EU-MARINE_ENVIRONMENTAL_POLICY-ART_3_8
EU-MARINE_ENVIRONMENTAL_POLICY-ART_3_8
Marine Environmental Policy Framework Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 2008/56/EC (Marine Strategy Framework Directive), 25 June 2008, amended by Directive 2017/845/EU, 18 May 2017
This list contains a non-exhaustive inventory of hazardous substances for purposes of the Marine Strategy Framework Directive, especially as it concerns Art. 3(8), and Annexes I and III. The listed substances meet the European Union's definitions as hazardous, as provided on: (1) Table 3 of Annex VI to the CLP Regulation (1272/2008/EC); (2) Annex III of Directive 2000/54/EC (Biological Agents); Candidate List of SVHCs; and REACH Annex XIV (Authorisation List).
Last updated 03 May 2024. Database contains 5402 unique substances/entries.
Filter the list
|
203-585-2
|
108-46-3
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
A complex combination derived from wood, especially pine wood. Composed primarily of resin acids and modified resin acids such as dimers and decarboxylated resin acids. Includes rosin stabilized by catalytic disproportionation.
|
232-475-7
|
8050-09-7
|
yes |
|||
|
-
|
-
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
R-GLYCIDOL
|
404-660-4
|
57044-25-4
|
yes |
|||
|
436-690-9
|
220727-26-4
|
yes |
||||
|
ALKYL ISOCYANATE SILANE SCD 617
|
402-290-8
|
85702-90-5
|
yes |
|||
|
-
|
953-17-3
|
yes |
||||
|
X4261
|
401-850-9
|
255881-94-8
|
yes |
|||
|
620-370-2
|
2703-37-9
|
yes |
||||
|
-
|
2635-50-9
|
yes |
||||
|
249-013-5
|
28434-00-6
|
yes |
||||
|
243-193-9
|
19622-19-6
|
yes |
||||
|
618-004-1
|
87392-12-9
|
yes |
||||
|
617-100-0
|
8051-02-3
|
yes |
||||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||||
|
202-345-4
|
94-59-7
|
yes |
||||
|
200-712-3
|
69-72-7
|
yes |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
-
|
B Bacteria and similar species |
||||
|
-
|
68583-35-7
|
B Bacteria and similar species |
||||
|
425-210-3
|
169939-84-8
|
yes |
||||
|
-
|
-
|
yes |
||||
|
-
|
-
|
yes |
||||
|
-
|
-
|
yes |
||||
|
show/hide
2-sec-butyl-4,6-dinitrophenol, compound with 2,2'-iminodiethanol (1:1)
EC / List no:
258-532-6
| CAS no:
53404-43-6
2-sec-butyl-4,6-dinitrophenol, compound with 2,2',2''-nitrilotriethanol (1:1)
EC / List no:
229-166-4
| CAS no:
6420-47-9
2-sec-butyl-4,6-dinitrophenol, compound with 1-aminopropan-2-ol (1:1)
EC / List no:
275-931-0
| CAS no:
71735-19-8
|
-
|
-
|
yes |
|||
|
show/hide
|
-
|
-
|
yes |
|||
|
-
|
-
|
yes |
||||
|
-
|
-
|
yes |
||||
|
-
|
-
|
yes |
||||